Recent HIV-1 infection in a high-risk Ugandan cohort: Implications for Phase IIB test-of-concept HIV vaccine trials

Pharmacogenomics

Volumn 8, Issue 4, 2007, Pages 409-414

  Kebba, Anthony ^a   Imami, Nesrina ^b   Bugembe Lule, Daniel ^a   Senkaali, David ^a   Kaleebu, Pontiano ^a   Grosskurth, Heiner ^a   Gotch, Frances ^b  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

HIV 1; Phase IIB test of concept trials; Recent infection; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT; HLA ANTIGEN CLASS 1; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ALLELE; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA MATCHING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PHYLOGENY; SEXUAL BEHAVIOR; UGANDA; VIREMIA; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; AIDS VACCINES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; RISK FACTORS; UGANDA; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34247134009     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.4.409     Document Type: Article

References (15)

1. Trask SA, Derdeyn CA, Fideli U et al.: Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia. J. Virol. 76, 397-405 (2002).
2. Fideli US, Allen SA, Musonda R et al.: Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res. Hum. Retroviruses 17, 901-910 (2001).
3. Kebba A, Kaleebu P, Rowland S et al.: Distinct patterns of peripheral HIV-1-specific interferon-γ responses in exposed HIV-1-seronegative individuals. J. Infect. Dis. 189, 1705-1713 (2004).
4. McMichael AJ, Phillips RE: Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15, 271-296 (1997).
5. Lyles RH, Munoz A, Yamashita TE et al.: Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J. Infect. Dis. 181, 872-880 (2000).
6. Dorak MT, Tang J, Penman-Aguilar A et al.: Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples. Lancet 363, 2137-2139 (2004).
7. Allen S, Meinzen-Derr J, Kautzman M et al.: Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS 17, 733-740 (2003).
8. Quinn T, Wawer MJ, Sewankambo N et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. N. Engl. J. Med. 342, 921-929 (2000).
9. Castilla J, del Romero J, Hernando V et al.: Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J. Acquir. Immune Defic. Syndr. 40, 96-101 (2005).
10. Goulder PJ, Brander C, Tang Y et al.: Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412, 334-338 (2001).
11. Draenert R, Le Gall S, Pfafferott KJ et al.: Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 199, 905-915 (2004).
12. Yokomaku Y, Miura H, Tomiyama H et al.: Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. J. Virol. 78, 1324-1332 (2004).
13. Barouch DH, Kunstman J, Kuroda MJ et al.: Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415, 335-339 (2002).
14. Hel Z, Tsai WP, Tryniszewska E et al.: Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes. J. Immunol. 176, 85-96 (2006).
15. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M: Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434, 1093-1097 (2005).